EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons

Natalia Roson-Calero iD, Clara Ballesté-Delpierre iD, Javier Fernández, Jordi Vila iD

Antibiotics · 19.06.2023 · 12 (6) · 1074

DOI: 10.3390/antibiotics12061074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 19.06.2023. Verfasst von Natalia Roson-Calero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Barcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the last decades, we have witnessed a steady increase in infections caused by multidrug-resistant (MDR) bacteria. These infections are associated with higher morbidity and mortality. Several interventions should be taken to reduce the emergence and spread of MDR bacteria. The eradication of resistant pathogens colonizing specific human body sites that would likely cause further infection in other sites is one of the most conventional strategies. The objective of this narrative mini-review is to compile and discuss different strategies for the eradication of MDR bacteria from gut microbiota. Here, we analyse the prevalence of MDR bacteria in the community and the hospital and the clinical impact of gut microbiota colonisation with MDR bacteria. Then, several strategies to eliminate MDR bacteria from gut microbiota are described and include: (i) selective decontamination of the digestive tract (SDD) using a cocktail of antibiotics; (ii) the use of pre and probiotics; (iii) fecal microbiota transplantation; (iv) the use of specific phages; (v) engineered CRISPR-Cas Systems. This review intends to provide a state-of-the-art of the most relevant strategies to eradicate MDR bacteria from gut microbiota currently being investigated.

Schlagwörter

Stichwörter der Autor:innen

CRISPR-Casbacteriotherapydecolonizationfecal microbiota transplantationgut microbiomemultidrug-resistant bacteriaphage therapy

Autor:innen und Institutionen

  • Barcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain.
  • Department of Basic Clinical Practice, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
  • CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto Salud Carlos III, 28029 Madrid, Spain.
  • Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, 08036 Barcelona, Spain.
  • European Foundation for the Study of Chronic Liver Failure (EF-Clif), 08021 Barcelona, Spain.
  • Department of Clinical Microbiology, Biomedical Diagnostic Center, Hospital Clinic, 08036 Barcelona, Spain.

ORCID-Profile: Natalia Roson-Calero, Clara Ballesté-Delpierre, Jordi Vila

Zitieren

APA

Roson-Calero, N., Ballesté-Delpierre, C., Fernández, J., & Vila, J. (2023). Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons. Antibiotics, 12(6), 1074. https://doi.org/10.3390/antibiotics12061074

Vancouver

Roson-Calero N, Ballesté-Delpierre C, Fernández J, Vila J. Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons. Antibiotics. 2023;12(6):1074. doi:10.3390/antibiotics12061074

BibTeX
@article{RosonCalero2023,
  author = {Roson-Calero, Natalia and Ballesté-Delpierre, Clara and Fernández, Javier and Vila, Jordi},
  title = {Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons},
  journal = {Antibiotics},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {1074},
  doi = {10.3390/antibiotics12061074}
}
Kostenlos starten →